Table of Contents Author Guidelines Submit a Manuscript
Computational Intelligence and Neuroscience
Volume 2018, Article ID 3094504, 7 pages
https://doi.org/10.1155/2018/3094504
Research Article

Liraglutide Activates the Nrf2/HO-1 Antioxidant Pathway and Protects Brain Nerve Cells against Cerebral Ischemia in Diabetic Rats

1Department of Neurology, The Fifth Affiliated Hospital of Zunyi Medical College, Zhuhai 519100, China
2Department of Pharmacy, Xindu District People’s Hospital of Chengdu, Chengdu 610500, China
3Department of Emergency, The Fifth Affiliated Hospital of Zunyi Medical College, Zhuhai 519100, China
4Department of Neurology, Zhuhai People’s Hospital, Zhuhai 519100, China

Correspondence should be addressed to Jiangquan Han; moc.361@qjnahsdg

Received 21 September 2017; Revised 15 December 2017; Accepted 27 December 2017; Published 12 February 2018

Academic Editor: João Manuel R. S. Tavares

Copyright © 2018 Caihong Deng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Mozaffarian, E. J. Benjamin, and A. S. Go, “Executive summary: heart disease and stroke statistics—2016 update: a report from the American Heart Association,” Circulation, vol. 133, pp. 447–454, 2016. View at Google Scholar
  2. A. G. Thrift, D. A. Cadilhac, T. Thayabaranathan et al., “Global stroke statistics,” International Journal of Stroke, vol. 9, no. 1, pp. 6–18, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Meierhans, M. Béchir, S. Ludwig et al., “Brain metabolism is significantly impaired at blood glucose below 6 mM and brain glucose below 1 mM in patients with severe traumatic brain injury,” Critical Care, vol. 14, no. 1, article no. R13, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Vilsbøll, “Liraglutide: A new treatment for type 2 Diabetes,” Drugs of Today, vol. 45, no. 2, pp. 101–113, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Sato, M. Kameda, T. Yasuhara et al., “Neuroprotective effects of liraglutide for stroke model of rats,” International Journal of Molecular Sciences, vol. 14, no. 11, pp. 21513–21524, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Sun, G. Yang, H. Zhao, H. F. J. Savelkoul, and L. An, “Multidose streptozotocin induction of diabetes in BALB/c mice induces a dominant oxidative macrophage and a conversion of TH1 to T H2 phenotypes during disease progression,” Mediators of Inflammation, vol. 2005, no. 4, pp. 202–209, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Z. Longa, P. R. Weinstein, S. Carlson, and R. Cummins, “Reversible middle cerebral artery occlusion without craniectomy in rats,” Stroke, vol. 20, no. 1, pp. 84–91, 1989. View at Publisher · View at Google Scholar · View at Scopus
  8. F. D. Administration, “Guidance for industry: estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers,” 2005.
  9. V. Darsalia, S. Mansouri, H. Ortsäter et al., “Glucagon-like peptide-1 receptor activation reduces ischaemic brain damage following stroke in type 2 diabetic rats,” Clinical Science, vol. 122, no. 10, pp. 473–483, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. R. A. Frieler, H. Meng, S. Z. Duan et al., “Myeloid-specific deletion of the mineralocorticoid receptor reduces infarct volume and alters inflammation during cerebral ischemia,” Stroke, vol. 42, no. 1, pp. 179–185, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Kakkar, B. Das, and P. N. Viswanathan, “A modified spectrophotometric assay of superoxide dismutase,” Indian Journal of Biochemistry and Biophysics, vol. 21, no. 2, pp. 130–132, 1984. View at Google Scholar · View at Scopus
  12. L. M. Hillefass, D. E. Griswold, B. Brickson, and C. Albrightson-Winslow, “Assessment of myeloperoxidase activity in whole rat kidney,” Journal of Pharmacological Methods, vol. 24, no. 4, pp. 285–295, 1990. View at Publisher · View at Google Scholar · View at Scopus
  13. J. F. Meschia, C. Bushnell, B. Boden-Albala et al., “Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association,” Stroke, vol. 45, no. 12, pp. 3754–3832, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Kostulas, I. Markaki, H. Cansu, T. Masterman, and V. Kostulas, “Hyperglycaemia in acute ischaemic stroke is associated with an increased 5-year mortality,” Age and Ageing, vol. 38, no. 5, pp. 590–594, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Vijayan and P. H. Reddy, “Peripheral biomarkers of stroke: focus on circulatory microRNAs,” Biochimica et Biophysica Acta, vol. 1862, no. 10, pp. 1984–1993, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Santilli, D. Lapenna, S. La Barba, and G. Davì, “Oxidative stress-related mechanisms affecting response to aspirin in diabetes mellitus,” Free Radical Biology & Medicine, vol. 80, pp. 101–110, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Forsberg, C. Xu, J. Grünler et al., “Coenzyme Q10 and oxidative stress, the association with peripheral sensory neuropathy and cardiovascular disease in type 2 diabetes mellitus,” Journal of Diabetes and its Complications, vol. 29, no. 8, pp. 1152–1158, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Zagoura, D. Canovas-Jorda, F. Pistollato, S. Bremer-Hoffmann, and A. Bal-Price, “Evaluation of the rotenone-induced activation of the Nrf2 pathway in a neuronal model derived from human induced pluripotent stem cells,” Neurochemistry International, vol. 106, pp. 62–73, 2017. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Tu, X. Zhang, Y. Zhu et al., “Cell-permeable peptide targeting the Nrf2-keap1 interaction: A potential novel therapy for global cerebral ischemia,” The Journal of Neuroscience, vol. 35, no. 44, pp. 14727–14739, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Jiang, X. Liu, M. Wang, H. Chen, Z. Chen, and T. Qiu, “Oxymatrine ameliorates renal ischemia-reperfusion injury from oxidative stress through Nrf2/HO-1 pathway,” Acta Cirurgica Brasileira, vol. 30, no. 6, pp. 422–429, 2015. View at Publisher · View at Google Scholar
  21. Z. Yang, C. Weian, H. Susu, and W. Hanmin, “Protective effects of mangiferin on cerebral ischemia-reperfusion injury and its mechanisms,” European Journal of Pharmacology, vol. 771, pp. 145–151, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. S.-S. Shi, W.-Z. Yang, Y. Chen, J.-P. Chen, and X.-K. Tu, “Propofol reduces inflammatory reaction and ischemic brain damage in cerebral ischemia in rats,” Neurochemical Research, vol. 39, no. 5, pp. 793–799, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Fujita, T. Morii, H. Fujishima et al., “The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential,” Kidney International, vol. 85, no. 3, pp. 579–589, 2014. View at Publisher · View at Google Scholar · View at Scopus